OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

VTGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

VistaGen Therapeutics (VTGN) Earnings Date & Reports

Vistagen Therapeutics Inc is a biotechnology firm... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VTGN is expected to report earnings to fall 88.64% to -5 cents per share on June 27

VistaGen Therapeutics VTGN Stock Earnings Reports

Q1'23

Est.

$-0.05

Q1'25

Beat

by $0.41

Q2'23

Beat

by $1.31

Q4'22

Beat

by $0.02

Q3'22

Missed

by $0.01

The last earnings report on June 17 showed earnings per share of -43 cents, beating the estimate of -85 cents. With 222.35K shares outstanding, the current market capitalization sits at 57.44M.

View a ticker or compare two or three

Compare

VTGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VTGN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

343 Allerton Avenue

Phone

+1 650 577-3600

Employees

Web

https://www.vistagen.com